-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Neutral on Health Catalyst, Lowers Price Target to $3

Benzinga·03/13/2026 13:21:48
Listen to the news
Cantor Fitzgerald analyst Sarah James maintains Health Catalyst (NASDAQ:HCAT) with a Neutral and lowers the price target from $4 to $3.